7 patents currently held
8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jul 2032. from the record
Of the 8 now held by other companies, 8 name Canon Kabushiki Kaisha as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jul 2032
Next term end
6
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jul 2032 · High confidence
Also notable
Ends Oct 2038 · High confidence
Also notable
Ends Dec 2038 · High confidence
Method for Determining Depression, Kit for Analyzing Serotonin Transporter, and Kit for Analyzing Ubiquitinated Serotonin Transporter in Blood
US 9,274,127
Granted 2016 and renewed at every maintenance window due so far. Protection runs to 2032.
Cytocidal Agent
US 11,357,819
The newest of the three, granted 2022. It anchors the portfolio to 2038, later than anything else here.
Cytocidal Agent
US 11,191,804
Granted 2021. Computed term ends 2038.
Formerly held, still cited
Notable
Ends Dec 2029 · High confidence
The most cited patent in this portfolio, cited by 24 later US patents, top 25% of utility patents granted in 2011 in our data. Protection runs to 2029.
now held by Canon Kabushiki Kaisha
Also notable
Ends Apr 2034 · High confidence
Granted 2017 and renewed at every maintenance window due so far. Protection runs to 2034.
now held by Canon Kabushiki Kaisha
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 14, 2027The maintenance fee for Cell and Utilization Thereof (US 11,814,651) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
- 1 fee due Sep 1, 2027The maintenance fee for Method for Determining Depression, Kit for Analyzing Serotonin Transporter, and Kit for Analyzing Ubiquitinated Serotonin Transporter in Blood (US 9,274,127) comes due Sep 1, 2027. Unpaid by Mar 1, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 5 largest of its 6 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Method for Determining Depression, Kit for Analyzing Serotonin Transporter, and Kit for Analyzing Ubiquitinated Serotonin Transporter in Blood | 2 in force | to Jul 2032 |
| Cell and Utilization Thereof | 1 in force | to Apr 2040 |
| beta-LACTAMASE INHIBITOR | 1 in force | to Aug 2039 |
| Cytocidal Agent (2020) | 1 in force | to Dec 2038 |
| Cytocidal Agent (2020) | 1 in force | to Oct 2038 |
Patents held now
Soonest term end first.
Showing 1 to 7 of 7
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,274,127 | Method for Determining Depression, Kit for Analyzing Serotonin Transporter, and Kit for Analyzing Ubiquitinated Serotonin Transporter in Blood In force · High confidence | In force | High confidence | |
| US 9,581,606 | Method for Determining Depression, Kit for Analyzing Serotonin Transporter, and Kit for Analyzing Ubiquitinated Serotonin Transporter in Blood In force · High confidence | In force | High confidence | |
| US 11,357,819 | Cytocidal Agent In force · High confidence | In force | High confidence | |
| US 11,191,804 | Cytocidal Agent In force · High confidence | In force | High confidence | |
| US 11,497,731 | beta-LACTAMASE INHIBITOR In force · High confidence | In force | High confidence | |
| US 11,814,651 | Cell and Utilization Thereof In force · High confidence | In force | High confidence | |
| US 12,555,254 | Medical Image Processing Apparatus, Medical Image Processing Apparatus Method, and Non-Transitory, Computer-Readable Medium held by Canon Medical Systems Corporation and Fujita Academy In force · High confidence | In force | High confidence |
Also on record, not counted in the 7: 8 patents in force now held by others · 1 patent ended · 20 applications pending · 3 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.